Gut microbiome in endometriosis: a cohort study on 1000 individualsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This case-control study investigated whether the gut microbiome is altered in women with endometriosis compared to women without the condition. Researchers used shotgun metagenomics to characterize microbial species composition and applied the KEGG database to annotate functional pathways. They also examined estrobolome-related enzymes to assess whether microbiome-driven estrogen metabolism differs in endometriosis, and used a clustering algorithm (Partitioning Around Medoids) to characterize microbial community profiles across the population.
Who was studied?
The study analyzed a subsample of 1000 women drawn from the Estonian Microbiome cohort. Within this group, 136 women had a diagnosis of endometriosis and 864 women served as controls. This is a large, population-based cohort rather than a small clinical sample, giving the analysis substantial statistical power.
What were the most important findings?
The abstract indicates that diversity analyses were performed to assess alpha- and beta-diversity along with differential abundance of species and functional gene pathways between women with and without endometriosis, but the specific results are cut off in the provided text. The study also mapped metagenomic reads to estrobolome-related enzyme sequences specifically to evaluate whether microbiome-estrogen metabolism interactions are altered in endometriosis. No specific taxa, diversity metrics, or estrobolome findings can be reported here because the abstract text was truncated before the results were presented.
What are the greatest implications of this study?
By using a large, well-characterized population cohort and combining taxonomic, functional, and estrobolome-focused analyses, this study is positioned to help clarify whether gut microbial dysbiosis contributes to endometriosis pathogenesis. If differences in microbial composition or estrogen-metabolizing functional pathways are confirmed, this could support the gut microbiome as a potential diagnostic or therapeutic target. However, because the results portion of the abstract was not fully available, firm conclusions about specific microbial targets cannot yet be drawn from this summary alone.